Skip to main content
. 2019 Jun 30;11(7):301. doi: 10.3390/pharmaceutics11070301

Figure 5.

Figure 5

Schematic representation of hyaluronic acid (HA)-coated carriers for cancer therapy (A) HA-indocyanine dye (IR-Pyr) micelle formation scheme. (B) The importance of HA for HA-IR-Pyr tumor accumulation; HA-IR-Pyr has better localization compared to IR-Pyr and IR-780 dyes. Reproduced from [40] with permission. Copyright 2017 The Royal Society of Chemistry.